EDGAR Filing Documents for 0001193125-19-029601

Form S-3/A - Registration statement under Securities Act of 1933: [Amend]

SEC Accession No. 0001193125-19-029601

Filing Date

2019-02-06

Accepted

2019-02-06 16:39:30

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3/A	d702521ds3a.htm	S-3/A	93075
2	EX-23.1	d702521dex231.htm	EX-23.1	1881
3	EX-23.2	d702521dex232.htm	EX-23.2	1563
	Complete submission text file	0001193125-19-029601.txt		97502

Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080

Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185

CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-228203 | Film No.: 19571999
SIC: 2834 Pharmaceutical Preparations